Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK-OV-3

An adenocarcinoma cell line established from the ascetic fluid of a 64 year old Caucasian female patient with ovarian carcinoma previously treated… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
PurposeAssessment of miR-424-3p mimic capability to sensitize SK-OV-3 and TOV-21G ovarian cancer cells to cisplatin by decreasing… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
Inflammation and inflammatory mediators are intimately linked with chemoresistance through complex pathways in the tumor… Expand
Is this relevant?
2014
2014
Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
The therapeutic potential of mixed micelles, made of PEG-PE and vitamin E co-loaded with curcumin and paclitaxel, was… Expand
  • table 1
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2012
2012
Chemometric study of retention on binary stationary phases in gas chromatography.
Using gas chromatography, data analysis is performed on a dataset consisting of 486 retention indices, 27 standards (ramified… Expand
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
OBJECTIVE Interactions between estrogen receptor signaling and the PI3K/Akt pathway are present in estrogen-dependent cancer… Expand
Is this relevant?
2006
2006
Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
OBJECTIVES The resistance of tumor cells to cisplatin remains a major cause of treatment failure in cancer patients. In this… Expand
Is this relevant?
2005
2005
11,11'-dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity.
11,11'-dideoxy-verticillin, a compound of the novel epidithiodioxopiprazine structural class, is isolated from the traditional… Expand
Is this relevant?
2005
2005
Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in numerous transformed cell… Expand
Is this relevant?
1997
1997
HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting.
Amplification and overexpression of the HER-2/neu proto-oncogene frequently coincide with an aggressive clinical course of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Amplification or overexpression of c-erbB-2/neu protooncogene, or both, occur frequently in many different types of human cancers… Expand
  • figure 2
  • figure I
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE